CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 
 

XFOR's EPS Net Growth by Quarter and Year

X4 Pharmaceuticals Inc's EPS Net results by quarter and year




XFOR EPS Net (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - -0.01 -0.26 -0.76
III Quarter September - -0.33 -0.60 -0.74
II Quarter June - -0.16 -0.72 -1.30
I Quarter March -0.26 -0.18 -1.23 -0.91
FY   -0.26 -0.68 -2.81 -3.71



XFOR EPS Net first quarter 2024 Y/Y Growth Comment
X4 Pharmaceuticals Inc in the first quarter 2024 recorded EPS net loss of $ -0.26 .

According to the results reported in the first quarter 2024, X4 Pharmaceuticals Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While X4 Pharmaceuticals Inc' s EPS Net no change of % ranks overall at the positon no. in the first quarter 2024.




XFOR EPS Net ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
X4 Pharmaceuticals Inc's first quarter 2024 EPS Net $ -0.26 XFOR's Income Statement
X4 Pharmaceuticals Inc's first quarter 2023 EPS Net $ -0.18 Quarterly XFOR's Income Statement
New: More XFOR's historic EPS Net Growth >>


XFOR EPS Net (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

X4 Pharmaceuticals Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q EPS Net Comment
Current accomplishment of -0.26 by X4 Pharmaceuticals Inc appear even more unfavourable compare to the -0.01 EPS net loss in the fourth quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential EPS Net growth. While X4 Pharmaceuticals Inc's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


XFOR's I. Quarter Q/Q EPS Net Comment
I. Quarter 2024 accomplishment of -0.26 by X4 Pharmaceuticals Inc look even worse considering the EPS net loss -0.01 in the previous quarter.

Within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc achieved highest sequential EPS Net growth. While X4 Pharmaceuticals Inc's EPS Net growth quarter on quarter, overall rank is .


X4 Pharmaceuticals Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ -0.76 $ -0.68 $ -0.93 $ -1.20 $ -1.76
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


X4 Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
XFOR's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for XFOR's Competitors
EPS Net Growth for X4 Pharmaceuticals Inc's Suppliers
EPS Net Growth for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2024
Biomarin Pharmaceutical Inc70.37%$ 70.370 
Merck and Co Inc 68.47%$ 68.468 
Eli Lilly And Company66.44%$ 66.443 
Lemaitre Vascular Inc 62.96%$ 62.963 
Lifevantage Corp62.50%$ 62.500 
Amphastar Pharmaceuticals Inc 62.00%$ 62.000 
Boston Scientific Corporation57.14%$ 57.143 
Vertex Pharmaceuticals Inc56.51%$ 56.506 
Integer Holdings Corporation51.28%$ 51.282 
Intuitive Surgical Inc 51.00%$ 51.000 
Electromed Inc 41.67%$ 41.667 
Medpace Holdings Inc 40.97%$ 40.969 
Biomx Inc 40.00%$ 40.000 
Shockwave Medical Inc 39.81%$ 39.806 
Harmony Biosciences Holdings inc 39.58%$ 39.583 
Select Medical Holdings Corp33.93%$ 33.929 
Merit Medical Systems Inc33.33%$ 33.333 
Stryker Corp33.12%$ 33.117 
Ufp Technologies Inc 29.13%$ 29.134 
Resmed Inc 29.11%$ 29.114 
Penumbra Inc27.27%$ 27.273 
United Therapeutics Corporation26.95%$ 26.955 
Encompass Health Corporation26.44%$ 26.437 
Option Care Health Inc 23.81%$ 23.810 
Semler Scientific inc 23.81%$ 23.810 
Healthcare Services Group Inc 23.53%$ 23.529 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com